123 related articles for article (PubMed ID: 21435698)
1. Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy.
Andresen MS; Sandven I; Brunborg C; Njaastad AM; Strekerud F; Abdelnoor M; Smith P; Abildgaard U
Thromb Res; 2011 Jun; 127(6):540-6. PubMed ID: 21435698
[TBL] [Abstract][Full Text] [Related]
2. Patient-level meta-analysis: effect of measurement timing, threshold, and patient age on ability of D-dimer testing to assess recurrence risk after unprovoked venous thromboembolism.
Douketis J; Tosetto A; Marcucci M; Baglin T; Cushman M; Eichinger S; Palareti G; Poli D; Tait RC; Iorio A
Ann Intern Med; 2010 Oct; 153(8):523-31. PubMed ID: 20956709
[TBL] [Abstract][Full Text] [Related]
3. Impact of sex and traditional cardiovascular risk factors on the risk of recurrent venous thromboembolism: results from the German MAISTHRO Registry.
Linnemann B; Zgouras D; Schindewolf M; Schwonberg J; Jarosch-Preusche M; Lindhoff-Last E
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):159-65. PubMed ID: 18277138
[TBL] [Abstract][Full Text] [Related]
4. Long-term prospective study of recurrent venous thromboembolism in patients younger than 50 years.
García-Fuster MJ; Forner MJ; Fernández C; Gil J; Vaya A; Maldonado L
Pathophysiol Haemost Thromb; 2005; 34(1):6-12. PubMed ID: 16293979
[TBL] [Abstract][Full Text] [Related]
5. Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry.
Verso M; Agnelli G; Ageno W; Imberti D; Moia M; Palareti G; Pistelli R; Cantone V;
Thromb Res; 2012 Sep; 130(3):369-73. PubMed ID: 22583838
[TBL] [Abstract][Full Text] [Related]
6. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
[TBL] [Abstract][Full Text] [Related]
7. Long-term prospective study of recurrent venous thromboembolism in a Hispanic population.
Mello TB; Orsi FL; Montalvao SA; Ozelo MC; de Paula EV; Annichinno-Bizzachi JM
Blood Coagul Fibrinolysis; 2010 Oct; 21(7):660-5. PubMed ID: 20829682
[TBL] [Abstract][Full Text] [Related]
8. Incidence and predictors of venous thromboembolism in post-acute care patients. A prospective cohort study.
Scannapieco G; Ageno W; Airoldi A; Bonizzoni E; Campanini M; Gussoni G; Silingardi M; Valerio A; Zilli C; Iori I;
Thromb Haemost; 2010 Oct; 104(4):734-40. PubMed ID: 20664897
[TBL] [Abstract][Full Text] [Related]
9. Thrombin generation and activated protein C resistance in the absence of factor V Leiden correlates with the risk of recurrent venous thromboembolism in women aged 18-65 years.
Sonnevi K; Tchaikovski SN; Holmström M; Rosing J; Bremme K; Lärfars G
Thromb Haemost; 2011 Nov; 106(5):901-7. PubMed ID: 21947267
[TBL] [Abstract][Full Text] [Related]
10. Sex-specific risk factors for recurrent venous thromboembolism.
Olié V; Zhu T; Martinez I; Scarabin PY; Emmerich J
Thromb Res; 2012 Jul; 130(1):16-20. PubMed ID: 22100316
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival of patients with a history of venous thromboembolism.
Reitter SE; Waldhoer T; Mayerhofer M; Eigenbauer E; Ay C; Kyrle PA; Pabinger I
Ann Hematol; 2011 May; 90(5):585-94. PubMed ID: 21287349
[TBL] [Abstract][Full Text] [Related]
12. Elevated white blood cell count and outcome in cancer patients with venous thromboembolism. Findings from the RIETE Registry.
Trujillo-Santos J; Di Micco P; Iannuzzo M; Lecumberri R; Guijarro R; Madridano O; Monreal M;
Thromb Haemost; 2008 Nov; 100(5):905-11. PubMed ID: 18989537
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory bowel disease is a risk factor for recurrent venous thromboembolism.
Novacek G; Weltermann A; Sobala A; Tilg H; Petritsch W; Reinisch W; Mayer A; Haas T; Kaser A; Feichtenschlager T; Fuchssteiner H; Knoflach P; Vogelsang H; Miehsler W; Platzer R; Tillinger W; Jaritz B; Schmid A; Blaha B; Dejaco C; Eichinger S
Gastroenterology; 2010 Sep; 139(3):779-87, 787.e1. PubMed ID: 20546736
[TBL] [Abstract][Full Text] [Related]
14. Risk of recurrent venous thromboembolism after a first oestrogen-associated episode. Data from the REVERSE cohort study.
Le Gal G; Kovacs MJ; Carrier M; Do K; Kahn SR; Wells PS; Anderson DA; Chagnon I; Solymoss S; Crowther M; Righini M; Lacut K; White RH; Vickars L; Rodger M
Thromb Haemost; 2010 Sep; 104(3):498-503. PubMed ID: 20539910
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism: risk factors for recurrence.
Zhu T; Martinez I; Emmerich J
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
[TBL] [Abstract][Full Text] [Related]
16. Serum lipoprotein (a) levels in patients with first unprovoked venous thromboembolism is not associated with subsequent risk of recurrent VTE.
Rodger MA; Le Gal G; Carrier M; Betancourt MT; Kahn SR; Wells PS; Anderson DA; Lacut K; Chagnon I; Solymoss S; Crowther M; Perrier A; White R; Vickars L; Ramsay T; Kovacs MJ
Thromb Res; 2010 Sep; 126(3):222-6. PubMed ID: 20580413
[TBL] [Abstract][Full Text] [Related]
17. Risk of venous thromboembolism recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.
Palareti G; Legnani C; Cosmi B; Guazzaloca G; Pancani C; Coccheri S
Thromb Haemost; 2002 Jan; 87(1):7-12. PubMed ID: 11848459
[TBL] [Abstract][Full Text] [Related]
18. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
White RH; Chan WS; Zhou H; Ginsberg JS
Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
[TBL] [Abstract][Full Text] [Related]
19. Short-term clinical outcome after acute symptomatic pulmonary embolism.
Conget F; Otero R; Jiménez D; Martí D; Escobar C; Rodríguez C; Uresandi F; Cabezudo MA; Nauffal D; Oribe M; Yusen R
Thromb Haemost; 2008 Nov; 100(5):937-42. PubMed ID: 18989541
[TBL] [Abstract][Full Text] [Related]
20. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]